| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/08/2010 | US20100087532 Modulation of signal transduction |
| 04/08/2010 | US20100087531 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 04/08/2010 | US20100087527 Curcumin Derivatives |
| 04/08/2010 | US20100087526 Inhibitors of polyisoprenylated methylated protein methyl esterase |
| 04/08/2010 | US20100087525 Stereoselective enzymatic synthesis of (s) or (r)-iso-butyl-glutaric ester |
| 04/08/2010 | US20100087524 Flavour Improving Substances |
| 04/08/2010 | US20100087523 Rupestonic acid derivatives and use thereof |
| 04/08/2010 | US20100087522 Novel muscle relaxant using negative charge gold nanoparticle with choline |
| 04/08/2010 | US20100087521 Biologically active complex |
| 04/08/2010 | US20100087520 Stable solutions of orlistat for pharmaceutical dosage forms |
| 04/08/2010 | US20100087519 Use of equol for treating androgen mediated diseases |
| 04/08/2010 | US20100087518 Delta 9 - tetrahydrocannabinol processing |
| 04/08/2010 | US20100087517 Prodrugs of substituted 1,3-dioxanes and their uses |
| 04/08/2010 | US20100087516 Antibacterial macrolactin a that bacillus polyfermenticus kjs-2 produced in |
| 04/08/2010 | US20100087515 Ikk-beta serine-threonine protein kinase inhibitors |
| 04/08/2010 | US20100087514 Method and means for treatment of osteoarthritis |
| 04/08/2010 | US20100087513 Microrna molecules |
| 04/08/2010 | US20100087512 Microrna molecules |
| 04/08/2010 | US20100087511 Spinal muscular atrophy (sma) treatment via targeting of smn2 splice site inhibitory sequences |
| 04/08/2010 | US20100087509 Methods, Agents, and Compound Screening Assays for Inducing Differentiation of Undifferentiated Mammalian Cells into Osteoblasts |
| 04/08/2010 | US20100087508 Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes |
| 04/08/2010 | US20100087507 Use of rpn2 gene expression inhibitor |
| 04/08/2010 | US20100087506 Cyclic amine compound |
| 04/08/2010 | US20100087505 Compounds Having Aryl-Sulphonamidic Structure Useful As Metalloproteases Inhibitors |
| 04/08/2010 | US20100087504 Use of Diindolylmethane (DIM) Compounds and Derivatives as Neuroprotective Agents |
| 04/08/2010 | US20100087503 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 04/08/2010 | US20100087502 Indazoles Used To Treat Estrogen Receptor Beta Mediated Disorders |
| 04/08/2010 | US20100087501 Highly Bioavailable Composition Containing Eprosartan-Poloxamer Complex or 2-(7-Chloro-5-Methyl-4-Oxo-3-Phenyl-4,5-Dihydro-3H-Pyridazine (4,5-b)Indol-1-yl)-N,N-Dimethylacetamide - Poloxamer Complex |
| 04/08/2010 | US20100087500 Methods and Compositions for Treatment of Acute Heart Failure |
| 04/08/2010 | US20100087499 Pharmaceutical compositions and methods of using temozolomide and multi-targeted kinase inhibitors |
| 04/08/2010 | US20100087498 Use of biotin to prevent photoaging |
| 04/08/2010 | US20100087497 Benzimidazole Anthelmintic Compositions |
| 04/08/2010 | US20100087496 Novel cinnamic amide derivatives useful as ion channel modulators |
| 04/08/2010 | US20100087495 Phenyl derivatives and their use as immunomodulators |
| 04/08/2010 | US20100087493 Method for improving the pharmacokinetics of drugs metabolized by ugt2b10 |
| 04/08/2010 | US20100087492 Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent |
| 04/08/2010 | US20100087491 Polycyclic compounds |
| 04/08/2010 | US20100087490 Dosage Units of 3-(6-(1-(2,2-Difluorobenzo[D] [1,3] Dioxol-5-YL) Cyclopropanecarboxamido)-3-Methylpyridin-2-YL)Benzoic Acid |
| 04/08/2010 | US20100087489 Phenyl and Benzodioxinyl Substituted Indazoles Derivatives |
| 04/08/2010 | US20100087488 Physiologically Acceptable Salts of 3-[(2--1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester |
| 04/08/2010 | US20100087487 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| 04/08/2010 | US20100087486 Methods for using tgf-b receptor inhibitors or activin-like kinase (alk) 5 inhibitors a-83-01 and sb-431542 to treat eye disease and wound healing conditions |
| 04/08/2010 | US20100087485 4-aminopiperidine derivatives |
| 04/08/2010 | US20100087484 Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands |
| 04/08/2010 | US20100087483 Aminosulfonyl Substituted 4-(Aminomethyl)-Piperidine Benzamides As 5HT 4-Antagonists |
| 04/08/2010 | US20100087482 Method for Treating Gefitinib Resistant Cancer |
| 04/08/2010 | US20100087481 Oral pharmaceutical formulations for antidiabetic compounds |
| 04/08/2010 | US20100087480 Substituted phenylmethyl bicyclocarboxyamide compounds |
| 04/08/2010 | US20100087479 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels |
| 04/08/2010 | US20100087478 HIF-1 Inhibitors |
| 04/08/2010 | US20100087477 Selective glycosidase inhibitors |
| 04/08/2010 | US20100087476 Pharmaceutical compounds |
| 04/08/2010 | US20100087475 Pharmaceutical compounds |
| 04/08/2010 | US20100087474 Materials and methods for enhanced degradation of mutant proteins associated with human disease |
| 04/08/2010 | US20100087473 Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature |
| 04/08/2010 | US20100087472 Use of methylnaltrexone and related compound to treat constipation in chronic opioid users |
| 04/08/2010 | US20100087471 Indole and indoline derivatives and methods of use thereof |
| 04/08/2010 | US20100087470 Buprenorphine-Wafer for Drug Substitution Therapy |
| 04/08/2010 | US20100087469 extracts of Ocimum sanctum and their derivatives, having desirable biological activity and toxicity profiles, used for the enhanced treatment of malaria |
| 04/08/2010 | US20100087468 Modulators of ppar and methods of their preparation |
| 04/08/2010 | US20100087467 Compositions Useful As Inhibitors of Protein Kinases |
| 04/08/2010 | US20100087466 Novel small molecule dnak inhibitors |
| 04/08/2010 | US20100087465 Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
| 04/08/2010 | US20100087464 Protein kinase inhibitors and methods for using thereof |
| 04/08/2010 | US20100087463 Pharmaceutical compositions comprising nilotinib or its salt |
| 04/08/2010 | US20100087462 Methods for predicting and detecting intolerance to an hypolipidemic agent |
| 04/08/2010 | US20100087461 Arylamide pyrimidone compounds |
| 04/08/2010 | US20100087460 Arylamide pyrimidone derivatives |
| 04/08/2010 | US20100087459 Forms of lapatinib compounds and processes for the preparation thereof |
| 04/08/2010 | US20100087458 Method of treating melanoma |
| 04/08/2010 | US20100087457 Dosages and methods for the treatment of cancer |
| 04/08/2010 | US20100087456 PYRIDOPYRIMIDINONE INHIBITORS OF PI3K-ALPHA and mTOR |
| 04/08/2010 | US20100087455 Substituted xanthine compounds |
| 04/08/2010 | US20100087454 Mucosal bioadhesive slow release carrier for delivering active principles |
| 04/08/2010 | US20100087453 Compounds, screens, and methods of treatment |
| 04/08/2010 | US20100087451 Polymorph b of n--n-methyl-acetamide |
| 04/08/2010 | US20100087450 Organic compounds |
| 04/08/2010 | US20100087449 Heteroarylamide pyrimidone compounds |
| 04/08/2010 | US20100087448 Dihydropyrimidine Compounds and Their Uses in Preparation of Medicaments for Treating and Preventing Antiviral Diseases |
| 04/08/2010 | US20100087447 Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination |
| 04/08/2010 | US20100087446 2-substituted indole derivatives as calcium channel blockers |
| 04/08/2010 | US20100087445 Aryl piperazine derivatives useful for the treatment of neuropsychiatry disorders |
| 04/08/2010 | US20100087444 Imatinib mesylate |
| 04/08/2010 | US20100087443 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7) modulators |
| 04/08/2010 | US20100087442 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/08/2010 | US20100087441 Prognostic Method |
| 04/08/2010 | US20100087440 Phosphatidylinositol 3-Kinase Inhibitors and Methods of Their Use |
| 04/08/2010 | US20100087439 Novel preventive and/or therapeutic agent for neuropathic pain |
| 04/08/2010 | US20100087438 New Potassium Channel Blockers |
| 04/08/2010 | US20100087437 Novel Potassium Channel Blockers |
| 04/08/2010 | US20100087436 Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection |
| 04/08/2010 | US20100087435 Modulators of atp-binding cassette transporters |
| 04/08/2010 | US20100087434 NK-1 and Serotonin Transporter Inhibitors |
| 04/08/2010 | US20100087433 Methods of inhibiting tryptophan hydroxylase |
| 04/08/2010 | US20100087432 Pyrrole derivatives having crth2 receptor antagonist activity |
| 04/08/2010 | US20100087431 Triazolyl aminopyrimidine compounds |
| 04/08/2010 | US20100087430 Novel benzofuran potassium channel blockers and uses thereof |
| 04/08/2010 | US20100087429 Spiro-tricyclic ring compounds as beta-secretase modulators and methods of use |
| 04/08/2010 | US20100087428 Novel Potassium Channel Blockers |
| 04/08/2010 | US20100087427 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |